- Joined
- Mar 6, 2016
- Messages
- 1,821
- Reaction score
- 3,240
I hope that I'm not being redundant by raising a previously-asked question ...
I've heard about Australian researchers are testing whether the Japanese tuberculosis drug Bacillus Calmette-Guerin (BCG) as a possible treatment of COVID-19.
This makes me wonder: Could BCG be one of the reasons for the lower infection statistics in Japan?
= = = = =
Beyond that, I'm sure everyone is up-to-speed on the situation. Here in the U.S., at least five companies have made noteworthy progress. Several companies have produced promising data, in connection with vaccine candidates, up to Phase II.
This is what I have heard through various sources:
I've heard about Australian researchers are testing whether the Japanese tuberculosis drug Bacillus Calmette-Guerin (BCG) as a possible treatment of COVID-19.
This makes me wonder: Could BCG be one of the reasons for the lower infection statistics in Japan?
= = = = =
Beyond that, I'm sure everyone is up-to-speed on the situation. Here in the U.S., at least five companies have made noteworthy progress. Several companies have produced promising data, in connection with vaccine candidates, up to Phase II.
This is what I have heard through various sources:
- A multiple-dose vaccine will probably be approved by the end of this year.
- A multiple-dose vaccine will probably be available to most by Spring or Summer 2021.
- Future Booster Shots might be necessary.
- Things could return to semi-normal by Summer or Fall 2021.
- Recent comments by Dr. Anthony Fauci seem to dovetail into those views.